These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 17504943

  • 1. Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine.
    Vernier-Massouille G, Cosnes J, Lemann M, Marteau P, Reinisch W, Laharie D, Cadiot G, Bouhnik Y, De Vos M, Boureille A, Duclos B, Seksik P, Mary JY, Colombel JF.
    Gut; 2007 Oct; 56(10):1404-9. PubMed ID: 17504943
    [Abstract] [Full Text] [Related]

  • 2. Incidence of nodular regenerative hyperplasia in inflammatory bowel disease patients treated with azathioprine.
    Seksik P, Mary JY, Beaugerie L, Lémann M, Colombel JF, Vernier-Massouille G, Cosnes J.
    Inflamm Bowel Dis; 2011 Feb; 17(2):565-72. PubMed ID: 20848502
    [Abstract] [Full Text] [Related]

  • 3. 6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension.
    Ferlitsch A, Teml A, Reinisch W, Ulbrich G, Wrba F, Homoncik M, Gangl A, Peck-Radosavljevic M, Vogelsang H.
    Am J Gastroenterol; 2007 Nov; 102(11):2495-503. PubMed ID: 17894846
    [Abstract] [Full Text] [Related]

  • 4. Azathioprine induced nodular regenerative hyperplasia in IBD patients.
    Daniel F, Cadranel JF, Seksik P, Cazier A, Duong Van Huyen JP, Ziol M, Coutarel P, Loison P, Jian R, Marteau P.
    Gastroenterol Clin Biol; 2005 May; 29(5):600-3. PubMed ID: 15980758
    [Abstract] [Full Text] [Related]

  • 5. [Portal vein hypertension during azathioprine therapy in patients with Crohn's disease--a frequent phenomenon?].
    Ehmsen L, Marko C, Breidert M.
    Dtsch Med Wochenschr; 2008 May; 133(18):950-3. PubMed ID: 18431703
    [Abstract] [Full Text] [Related]

  • 6. Review article: the association between nodular regenerative hyperplasia, inflammatory bowel disease and thiopurine therapy.
    Musumba CO.
    Aliment Pharmacol Ther; 2013 Nov; 38(9):1025-37. PubMed ID: 24099468
    [Abstract] [Full Text] [Related]

  • 7. Azathioprine induced serious portal hypertension: a case series of three IBD patients and review of the literature.
    Dooremont D, Decaestecker J, De Wulf D, Ghillebert G, Van Vlierberghe H, Van Dorpe J, Baert F.
    Acta Gastroenterol Belg; 2013 Sep; 76(3):342-6. PubMed ID: 24261031
    [Abstract] [Full Text] [Related]

  • 8. [Nodular regenerative hyperplasia as a side effect of azathioprine in a patient with Crohn's disease].
    Schumann M, Preiss JC, Loddenkemper C, Günther U, Somasundaram R, Siegmund B, Zeitz M.
    Dtsch Med Wochenschr; 2008 Sep; 133(38):1897-900. PubMed ID: 18788068
    [Abstract] [Full Text] [Related]

  • 9. Nodular regenerative hyperplasia: a reversible entity associated with azathioprine therapy.
    Seiderer J, Zech CJ, Diebold J, Schoenberg SO, Brand S, Tillack C, Göke B, Ochsenkühn T.
    Eur J Gastroenterol Hepatol; 2006 May; 18(5):553-5. PubMed ID: 16607155
    [Abstract] [Full Text] [Related]

  • 10. The Prevalence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Thioguanine Is Not Associated with Clinically Significant Liver Disease.
    van Asseldonk DP, Jharap B, Verheij J, den Hartog G, Westerveld DB, Becx MC, Russel MG, Engels LG, de Jong DJ, Witte BI, Mulder CJ, van Nieuwkerk CM, Bloemena E, de Boer NK, van Bodegraven AA.
    Inflamm Bowel Dis; 2016 Sep; 22(9):2112-20. PubMed ID: 27482972
    [Abstract] [Full Text] [Related]

  • 11. Histopathology of liver biopsies from a thiopurine-naïve inflammatory bowel disease cohort: prevalence of nodular regenerative hyperplasia.
    De Boer NK, Tuynman H, Bloemena E, Westerga J, Van Der Peet DL, Mulder CJ, Cuesta MA, Meuwissen SG, Van Nieuwkerk CM, Van Bodegraven AA.
    Scand J Gastroenterol; 2008 Sep; 43(5):604-8. PubMed ID: 18415755
    [Abstract] [Full Text] [Related]

  • 12. [Nodular regenerative hyperplasia of the liver associated with azathioprine therapy].
    Duvoux C, Kracht M, Lang P, Vernant JP, Zafrani ES, Dhumeaux D.
    Gastroenterol Clin Biol; 1991 Sep; 15(12):968-73. PubMed ID: 1783253
    [Abstract] [Full Text] [Related]

  • 13. Nodular regenerative hyperplasia of the liver secondary to azathioprine in a patient with inflammatory bowel disease.
    Bryant DL, Miles CJ, Gearry RB.
    N Z Med J; 2010 Apr 30; 123(1313):74-6. PubMed ID: 20581898
    [Abstract] [Full Text] [Related]

  • 14. Nodular regenerative hyperplasia of the liver: survival and associated features in a UK case series.
    Morris JM, Oien KA, McMahon M, Forrest EH, Morris J, Stanley AJ, Campbell S.
    Eur J Gastroenterol Hepatol; 2010 Aug 30; 22(8):1001-5. PubMed ID: 20075739
    [Abstract] [Full Text] [Related]

  • 15. Nodular regenerative liver hyperplasia as a complication of azathioprine-containing immunosuppressive treatment for Crohn's disease.
    Błogowski W, Marlicz W, Smereczyński A, Lawniczak M, Lewosiuk A, Starzyńska T.
    Immunopharmacol Immunotoxicol; 2011 Jun 30; 33(2):398-402. PubMed ID: 20726808
    [Abstract] [Full Text] [Related]

  • 16. The prevalence of nodular regenerative hyperplasia of the liver in long-term thiopurine-treated inflammatory bowel disease patients.
    Gilissen LPL, Tajzai R, Romberg M, Pierik M, Stronkhorst A, Steenhuisen K, Van Bodegraven A, Daniels A, Wong D.
    Eur J Gastroenterol Hepatol; 2021 Dec 01; 33(1S Suppl 1):e102-e107. PubMed ID: 33136726
    [Abstract] [Full Text] [Related]

  • 17. Adverse events of thiopurine immunomodulators in patients with inflammatory bowel disease.
    López-Martín C, Chaparro M, Espinosa L, Bejerano A, Maté J, Gisbert JP.
    Gastroenterol Hepatol; 2011 Dec 01; 34(6):385-92. PubMed ID: 21616565
    [Abstract] [Full Text] [Related]

  • 18. [Nodular regenerative hyperplasia as a complication of thiopurine treatment in a patient with inflammatory bowel disease].
    Cohen-Ezra O, Avni Y, Morgenstern S, Ben-Ari Z.
    Harefuah; 2012 Dec 01; 151(12):675-8, 721. PubMed ID: 23330258
    [Abstract] [Full Text] [Related]

  • 19. Clinical Course of Nodular Regenerative Hyperplasia in Thiopurine Treated Inflammatory Bowel Disease Patients.
    Simsek M, Meijer B, Ramsoekh D, Bouma G, van der Wouden EJ, den Hartog B, de Vries AC, Hoentjen F, Dijkstra G, de Boer SY, Jansen JM, van der Meulen AE, Beukers R, Brink MA, Steinhauser T, Oldenburg B, Gilissen LP, Naber TH, Verhagen MA, de Boer NKH, Mulder CJJ, Dutch Initiative on Crohn and Colitis (ICC).
    Clin Gastroenterol Hepatol; 2019 Feb 01; 17(3):568-570. PubMed ID: 29775790
    [Abstract] [Full Text] [Related]

  • 20. Assessment of non-cirrhotic portal hypertension associated with thiopurine therapy in inflammatory bowel disease.
    Calabrese E, Hanauer SB.
    J Crohns Colitis; 2011 Feb 01; 5(1):48-53. PubMed ID: 21272804
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.